Hikma Pharmaceuticals PLC

H5P

Company Profile

  • Business description

    Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

  • Contact

    1 New Burlington Place
    LondonW1S 2HR
    GBR

    T: +44 2073992760

    E: [email protected]

    https://www.hikma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    9,603

Stocks News & Analysis

stocks

Lowering profit forecasts on Aussie airlines

The impact of the oil price surge.
stocks

AI isn’t an economic moat killer, but it will disrupt industries

How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,571.30125.30-1.44%
CAC 407,743.9217.720.23%
DAX 4022,636.9116.95-0.07%
Dow JONES (US)46,300.2391.760.20%
FTSE 1009,965.1671.010.72%
HKSE25,063.71681.242.79%
NASDAQ21,842.29104.47-0.48%
Nikkei 22552,252.28736.791.43%
NZX 50 Index12,701.75288.24-2.22%
S&P 5006,578.712.29-0.03%
S&P/ASX 2008,379.40125.20-1.47%
SSE Composite Index3,881.2868.001.78%

Market Movers